Spectrum Pharmaceuticals, Inc. to Present Corporate Update at Credit Suisse 2012 Healthcare Conference in Phoenix on November 15th

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced that an overview of the Company's business strategy and commercial and development-stage programs will be given at the Credit Suisse 2012 Healthcare Conference being held at the Arizona Biltmore in Phoenix, Arizona. The Company presentation is on Thursday, November 15, 2012, at 8:30 AM MT.